Amylin Pharmaceuticals Announces Public Offering of Common Stock; No Amount Given
Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today announced that it is offering to sell shares of its common stock in an underwritten public offering.
Credit Suisse Securities LLC is acting as sole book-running manager and underwriter in this offering.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.